Source:http://linkedlifedata.com/resource/pubmed/id/11119270
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2001-1-23
|
pubmed:abstractText |
Central events in the host defence system and immune-mediated damage are tightly regulated by cell adhesion molecules. Sera from 28 human immunodeficiency virus (HIV)-1 infected children divided into groups according to disease severity, six seroreverting (SR) children and 25 healthy controls were studied to detect the presence of soluble intercellular adhesion molecule-1 (s-ICAM-1). Soluble ICAM-1 levels were found to be significantly increased in HIV-infected children in comparison with SR children or healthy controls. Levels of soluble ICAM-1 were higher in patients with severe forms of HIV-infection than in those with a milder form of the disease. Significant differences in titers of s-ICAM-1 were recorded between SR children and HIV-infected children with mild disease or healthy controls. There was a significant correlation between s-ICAM-1 levels and the concentrations of beta 2 microglobulin (beta 2m) and, to a lesser extend, immunoglobulin A levels (IgA). Soluble ICAM-1 levels didn't change considerably in HIV-infected children in stable clinical conditions, independently of their clinical stage of the disease, during a follow-up period of 9-12 months. Conversely, s-ICAM-1 levels increased simultaneously with the appearance of new well-defined clinical disorders or decreased during the improvement of clinical conditions. A significant negative correlation was recorded between the titers of the s-ICAM-1 and the CD4(+) T-cell levels. These results suggest that the s-ICAM-1 might be another useful tool to evaluate disease progression.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0300-9475
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
52
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
628-33
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11119270-Child,
pubmed-meshheading:11119270-Child, Preschool,
pubmed-meshheading:11119270-Female,
pubmed-meshheading:11119270-Follow-Up Studies,
pubmed-meshheading:11119270-HIV Infections,
pubmed-meshheading:11119270-HIV-1,
pubmed-meshheading:11119270-Humans,
pubmed-meshheading:11119270-Infant,
pubmed-meshheading:11119270-Intercellular Adhesion Molecule-1,
pubmed-meshheading:11119270-Male,
pubmed-meshheading:11119270-Predictive Value of Tests,
pubmed-meshheading:11119270-Prognosis,
pubmed-meshheading:11119270-Solubility
|
pubmed:year |
2000
|
pubmed:articleTitle |
Prognostic value of soluble intercellular adhesion molecule-1 (s-ICAM-1) in HIV-infected children.
|
pubmed:affiliation |
División Inmunología, Hospital Dr Pedro de Elizalde, Buenos Aires, Argentina. vgiradi@intramed.net.ar
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|